Improving Risk Assessment in the European Food Safety Authority: Lessons From the European Medicines Agency
Level 5 - mechanism / opinion, no new human data
Policy analysis and comparative institutional review without empirical data; graded Level 5 by design analogy.
OpenAlex W3011061018 · doi:10.3389/fpls.2020.00349
What was done
The authors evaluated regulatory amendments introduced by Regulation (EU) 2019/1381 to the General Food Law Regulation concerning food safety risk assessment. They conducted a qualitative institutional and organizational comparison between the European Food Safety Authority (EFSA) and the European Medicines Agency (EMA), focusing on risk assessment and evaluation procedures for genetically modified foods and pesticides and how these structures influence the politicization of regulatory decisions.
What was found
The abstract reports no quantitative metrics or numerical data. The authors concluded that EFSA's risk assessment processes would have been more effective and less susceptible to politicization if the 2019 regulatory reforms had integrated institutional structures and risk evaluation methodologies from the EMA.
Why it matters
It offers structural recommendations for EU food safety governance, proposing that EFSA adopt pharmaceutical-style institutional mechanisms to navigate public controversies surrounding pesticide and GMO risk assessments.
Limits
The work is a qualitative, narrative policy perspective without empirical datasets, experimental controls, or formal systematic review methodology. Concrete outcomes or implementations of the proposed organizational changes were not tested.
Cited by
- supports In the European Union, the scientific bodies that assess food safety risk are separated from the regulatory bodies that manage it, whereas in the United States both roles reside within the same agency.